Our publications
Collaborating with top academic partners, Ksilink’s scientists publish regularly in scientific reviews.
Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models.
June 2024, Translational Psychiatry
Read more
Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutation.
January 2024, Stem Cell Research& Therapy
Read more
Machine learning identifies phenotypic profile alterations of human dopaminergic neurons exposed to bisphenols and perfluoroalkyls.
December 2023, Scientific reports
Read more
Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9.
October 2023, Stem Cell Research
Read more
Addressing Global Environmental Challenges to Mental Health Using Population Neuroscience: A Review.
October 2023, JAMA Psychiatry
Read more
Revealing invisible cell phenotypes with conditional generative modeling.
October 2023, Nature Communications
Read more
Pharmacological modulation of developmental and synaptic phenotypes in human SHANK3 deficient stem cell-derived neuronal models.
September 2023, Preprint
Read more
Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons.
July 2023, JoVE Journal
Read more
Effects of urban living environments on mental health in adults.
June 2023, Nature Medicine
Read more
Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid.
December 2022, Cancer Biology & Therapy
Read more
CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder.
November 2022, Nature Communications
Read more
High-content phenotyping of Parkinson’s disease patient stem cell-derived midbrain dopaminergic neurons using machine learning classification.
September 2022, Stem Cell Reports
Read more
Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma.
June 2022, International Journal of Molecular Sciences
Read more
JUMP Cell Painting dataset: morphological impact of 136,000 chemical and genetic perturbations
March 2022, Preprint
Read more